129 related articles for article (PubMed ID: 17352228)
1. Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Porta C; Bonomi L; Lillaz B; Paglino C; Rovati B; Imarisio I; Morbini P; Villa C; Danova M; Mensi M; Rovereto B
Anticancer Res; 2007; 27(1A):165-73. PubMed ID: 17352228
[TBL] [Abstract][Full Text] [Related]
2. Immunological stress in kidney cancer patients undergoing either open nephrectomy or nephron-sparing surgery: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Porta C; Bonomi L; Lillaz B; Klersy C; Imarisio I; Paglino C; Rovati B; Danova M; Ferraris E; Mensi M; Rovereto B
Oncol Rep; 2008 Dec; 20(6):1511-9. PubMed ID: 19020735
[TBL] [Abstract][Full Text] [Related]
3. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
Ginaldi L; De Martinis M; D'Ostilio A; Marini L; Loreto F; Modesti M; Quaglino D
Am J Hematol; 2001 Jun; 67(2):63-72. PubMed ID: 11343377
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
6. Monitoring peri-operative immune suppression in renal cancer patients.
Hase S; Weinitschke K; Fischer K; Fornara P; Hoda R; Unverzagt S; Seliger B; Riemann D
Oncol Rep; 2011 May; 25(5):1455-64. PubMed ID: 21369703
[TBL] [Abstract][Full Text] [Related]
7. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
[TBL] [Abstract][Full Text] [Related]
8. Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.
Tassi E; Facchinetti V; Seresini S; Borri A; Dell'antonio G; Garavaglia C; Casorati G; Protti MP
Clin Cancer Res; 2006 Aug; 12(16):4949-57. PubMed ID: 16914584
[TBL] [Abstract][Full Text] [Related]
9. An assessment of lymphocytic population in peripheral blood of patients with renal cell carcinoma before and after embolization.
Osada J; Pietruczuk M; Dabrowska M; Kordecki K; Janica J; Walecki J
Rocz Akad Med Bialymst; 2000; 45():228-39. PubMed ID: 11712434
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
11. Impact of radiofrequency ablation on PBMC subpopulation in patients with renal cell carcinoma.
Matuszewski M; Michajłowski J; Michajłowski I; Ruckermann-Dizurdzińska K; Witkowski JM; Biernat W; Krajka K
Urol Oncol; 2011; 29(6):724-30. PubMed ID: 20189845
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk.
Cabillic F; Bouet-Toussaint F; Toutirais O; Rioux-Leclercq N; Fergelot P; de la Pintière CT; Genetet N; Patard JJ; Catros-Quemener V
Clin Exp Immunol; 2006 Dec; 146(3):518-23. PubMed ID: 17100773
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma.
Minárik I; Lašťovička J; Budinský V; Kayserová J; Spíšek R; Jarolím L; Fialová A; Babjuk M; Bartůňková J
Immunol Lett; 2013 May; 152(2):144-50. PubMed ID: 23721909
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.
Prado-Drayer A; Teppa J; Sánchez P; Camejo MI
Am J Reprod Immunol; 2008 Jul; 60(1):66-74. PubMed ID: 18593439
[TBL] [Abstract][Full Text] [Related]
17. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
Ferrari S; Rovati B; Cucca L; Scarabelli C; Presti M; Beccaria C; Collovà E; Porta C; Danova M
Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study.
Wei YC; Sticca RP; Li J; Holmes LM; Burgin KE; Jakubchak S; Bouton-Verville H; Williamson J; Meyer K; Evans L; Martin J; Stephenson JJ; Trocha S; Smith S; Wagner TE
Oncol Rep; 2007 Sep; 18(3):665-71. PubMed ID: 17671717
[TBL] [Abstract][Full Text] [Related]
19. Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
van der Vliet HJ; Koon HB; Yue SC; Uzunparmak B; Seery V; Gavin MA; Rudensky AY; Atkins MB; Balk SP; Exley MA
Clin Cancer Res; 2007 Apr; 13(7):2100-8. PubMed ID: 17404092
[TBL] [Abstract][Full Text] [Related]
20. Tumor infiltrating dendritic cells predict treatment response to immmunotherapy in patients with metastatic renal cell carcinoma.
Kobayashi M; Suzuki K; Yashi M; Yuzawa M; Takayashiki N; Morita T
Anticancer Res; 2007; 27(2):1137-41. PubMed ID: 17465253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
